Serum proteomics in biomedical research: A systematic review

Applied Biochemistry and Biotechnology

Volumn 170, Issue 4, 2013, Pages 774-786

  Zhang, Ai Hua ^a   Sun, Hui ^a   Yan, Guang Li ^a   Han, Ying ^a   Wang, Xi Jun ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Biomarkers; Disease diagnosis; Proteins; Proteomics; Serum; System biology

Indexed keywords

CLINICAL DIAGNOSTICS; DISEASE DIAGNOSIS; DISEASE DIAGNOSTICS; PROTEOMIC TECHNIQUES; PROTEOMIC TECHNOLOGIES; PROTEOMICS; SERUM; SYSTEM BIOLOGY;

BIOMARKERS; BODY FLUIDS; MOLECULAR BIOLOGY; PROTEINS;

DIAGNOSIS;

BIOLOGICAL MARKER; PLASMA PROTEIN;

ARTICLE; DIAGNOSTIC TEST; HUMAN; MEDICAL RESEARCH; PROTEIN BLOOD LEVEL; PROTEOMICS;

BLOOD PROTEINS; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; NEOPLASMS; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEOMICS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84878254491     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-013-0238-7     Document Type: Article

References (74)

1. Schwenk, J., Harmel, N., Zolles, G., Bildl, W., Kulik, A., Heimrich, B., Chisaka, O., Jonas, P., Schulte, U., Fakler, B., & Klöcker, N. (2009). Functional proteomics identify cornichon proteins as auxiliary subunits of AMPA receptors. Science, 323(5919), 1313-9.
2. Wang, X., Zhang, A., Han, Y., Wang, P., Sun, H., Song, G., Dong, T., Yuan, Y., Yuan, X., Zhang, M., Xie, N., Zhang, H., Dong, H., & Dong, W. (2012). Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Molecular & Cellular Proteomics, 11(8), 370-80.
3. Gutiérrez-Sánchez, G., Atwood, J., Kolli, V. S., Roussos, S., & Augur, C. (2012). Initial proteome analysis of caffeine-induced proteins in Aspergillus tamarii using two-dimensional fluorescence difference gel electrophoresis. Applied Biochemistry and Biotechnology, 166(8), 2064-77.
4. Wildes, D., & Wells, J. A. (2010). Sampling the N-terminal proteome of human blood. Proceedings of the National Academy of Sciences of the United States of America, 107(10), 4561-6.
5. Zhang, Y., Guo, B., & Bi, R. (2012). Ovarian cancer: biomarker proteomic diagnosis in progress. Applied Biochemistry and Biotechnology, 168(4), 910-6.
6. Zhang, A., Sun, H., Sun, W., Ye, Y., & Wang, X. (2013). Proteomic identification network analysis of haptoglobin as a key regulator associated with liver fibrosis. Applied Biochemistry and Biotechnology, 169(3), 832-46.
7. Marondedze, C., & Thomas, L. A. (2012). Apple hypanthium firmness: new insights from comparative proteomics. Applied Biochemistry and Biotechnology, 168(2), 306-26.
8. Aivado, M., Spentzos, D., Germing, U., Alterovitz, G., Meng, X. Y., Grall, F., Giagounidis, A. A., Klement, G., Steidl, U., Otu, H. H., Czibere, A., Prall, W. C., Iking-Konert, C., Shayne, M., Ramoni, M. F., Gattermann, N., Haas, R., Mitsiades, C. S., Fung, E. T., & Libermann, T. A. (2007). Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease. Proceedings of the National Academy of Sciences of the United States of America, 104(4), 1307-12.
9. Yu, C., Xu, C., Xu, L., Yu, J., Miao, M., & Li, Y. (2012). Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease. Journal of Hepatology, 56(1), 241-7.
10. Liu, W., Liu, B., Cai, Q., Li, J., Chen, X., & Zhu, Z. (2012). Proteomic identification of serum biomarkers for gastric cancer using multidimensional liquid chromatography and 2D differential gel electrophoresis. Clinical Chemical Acta, 413(13-14), 1098-106.
11. Wang, X., Zhang, A., & Sun, H. (2012). Future perspectives of Chinese medical formulae: chinmedomics as an effector. OMICS, 16(7-8), 414-21.
12. Chakraborty, C., Pal, S., Doss, C. G., Wen, Z. H., & Lin, C. S. (2012). In silico analysis of COMT, an important signaling cascade of dopaminergic neurotransmission pathway, for drug development of Parkinson's disease. Applied Biochemistry and Biotechnology, 167(4), 845-60.
13. Zhang, A., Sun, H., Wang, P., & Wang, X. (2013). Salivary proteomics in biomedical research. Clinica Chimica Acta, 415, 261-5.
14. Besson, D., Pavageau, A. H., Valo, I., Bourreau, A., Bélanger, A., Eymerit-Morin, C., Moulière, A., Chassevent, A., Boisdron-Celle, M., Morel, A., Solassol, J., Campone, M., Gamelin, E., Barré, B., Coqueret, O., & Guette, C. (2011). A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker. Molecular & Cellular Proteomics, 10(12), M111.009712.
15. Karthik, D., Ilavenil, S., Kaleeswaran, B., Sunil, S., & Ravikumar, S. (2012). Proteomic analysis of plasma proteins in diabetic rats by 2D electrophoresis and MALDI-TOF-MS. Applied Biochemistry and Biotechnology, 166(6), 1507-19.
16. Carlsson, A., Wuttge, D. M., Ingvarsson, J., Bengtsson, A. A., Sturfelt, G., Borrebaeck, C. A., & Wingren, C. (2011). Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays. Molecular & Cellular Proteomics, 10(5), M110.005033.
17. Wang, X., Zhang, A., Wang, P., Sun, H., Wu, G., Sun, W., Lv, H., Jiao, G., Xu, H., Yuan, Y., Liu, L., Zou, D., Wu, Z., Han, Y., Yan, G., Dong, W., Wu, F., Dong, T., Yu, Y., Zhang, S., Wu, X., Tong, X., & Meng, X. (2013). Metabolomics coupled with proteomics advancing drug discovery towards more agile development of targeted combination therapies. Molecular & Cellular Proteomics. doi: 10.1074/mcp.M112.021683.
18. Sun, H., Zhang, A., Yan, G., Han, Y., Sun, W., Ye, Y., & Wang, X. (2013). Proteomics study on the hepatoprotective effects of traditional Chinese medicine formulae Yin-Chen-Hao-Tang by a combination of two-dimensional polyacrylamide gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 75, 173-9.
19. Wang, X., Zhang, A., Sun, H., Wu, G., Sun, W., & Yan, G. (2012). Network generation enhances interpretation of proteomics data sets by a combination of two-dimensional polyacrylamide gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Analyst, 137(20), 4703-11.
20. Zhang, K., Yuan, K., Wu, H., Li, Q., Wang, Y., Chen, S., Zhang, L., Gu, H., & Fu, R. (2012). Identification of potential markers related to neoadjuvant chemotherapy sensitivity of breast cancer by SELDI-TOF MS. Applied Biochemistry and Biotechnology, 166(3), 753-63.
21. Arbing, M. A., Kaufmann, M., Phan, T., Chan, S., Cascio, D., & Eisenberg, D. (2010). The crystal structure of the Mycobacterium tuberculosis Rv3019c-Rv3020c ESX complex reveals a domain-swapped heterotetramer. Protein Science, 19(9), 1692-703.
22. Mobley, J. A., & Poliakov, A. (2009). Detection of early unfolding events in a dimeric protein by amide proton exchange and native electrospray mass spectrometry. Protein Science, 18(8), 1620-7.
23. Wu, Z., Doondeea, J. B., Gholami, A. M., Janning, M. C., Lemeer, S., Kramer, K., Eccles, S. A., Gollin, S. M., Grenman, R., Walch, A., Feller, S. M., & Kuster, B. (2011). Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer. Molecular & Cellular Proteomics, 10(12), M111.011635.
24. Wiltzius, J. J., Sievers, S. A., Sawaya, M. R., & Eisenberg, D. (2009). Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process. Protein Science, 18(7), 1521-30.
25. Sugiki, T., Yoshiura, C., Kofuku, Y., Ueda, T., Shimada, I., & Takahashi, H. (2009). High-throughput screening of optimal solution conditions for structural biological studies by fluorescence correlation spectroscopy. Protein Science, 18(5), 1115-20.
26. Edrei, Y., Gross, E., Corchia, N., & Abramovitch, R. (2012). Improved efficacy of a novel anti-angiogenic drug combination (TL-118) against colorectal-cancer liver metastases; MRI monitoring in mice. British Journal of Cancer, 107(4), 658-66.
27. Vafadar-Isfahani, B., Ball, G., Coveney, C., Lemetre, C., Boocock, D., Minthon, L., Hansson, O., Miles, A. K., Janciauskiene, S. M., Warden, D., Smith, A. D., Wilcock, G., Kalsheker, N., Rees, R., Matharoo-Ball, B., & Morgan, K. (2012). Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid. Journal of Alzheimer's Disease, 28(3), 625-36.
28. Afshar, S., Sawaya, M. R., & Morrison, S. L. (2009). Structure of a mutant human purine nucleoside phosphorylase with the prodrug, 2-fluoro-2′-deoxyadenosine and the cytotoxic drug, 2-fluoroadenine. Protein Science, 18(5), 1107-14.
29. Hew, C. S., & Gam, L. H. (2011). Proteome analysis of abundant proteins extracted from the leaf of Gynura procumbens (Lour.) Merr. Applied Biochemistry and Biotechnology, 165(7-8), 1577-86.
30. Cubedo, J., Padró, T., García-Moll, X., Pintó, X., Cinca, J., & Badimon, L. (2011). Proteomic signature of Apolipoprotein J in the early phase of new-onset myocardial infarction. Journal of Proteome Research, 10(1), 211-20.
31. Hu, S., Loo, J. A., & Wong, D. T. (2006). Human body fluid proteome analysis. Proteomics, 6(23), 6326-53.
32. Navaglia, F., Fogar, P., Basso, D., Greco, E., Padoan, A., Tonidandel, L., Fadi, E., Zambon, C. F., Bozzato, D., Moz, S., Seraglia, R., Pedrazzoli, S., & Plebani, M. (2009). Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry. Clinical Chemistry and Laboratory Medicine, 47(6), 713-23.
33. Lim, S. R., Gooi, B. H., Singh, M., & Gam, L. H. (2011). Analysis of differentially expressed proteins in colorectal cancer using hydroxyapatite column and SDS-PAGE. Applied Biochemistry and Biotechnology, 165(5-6), 1211-24.
34. Wang, X., Yang, B., Zhang, A., Sun, H., & Yan, G. (2012). Potential drug targets on insomnia and intervention effects of Jujuboside. A through metabolic pathway analysis as revealed by UPLC/ESI-SYNAPT-HDMS coupled with pattern recognition approach. Journal of Proteomics, 75(4), 1411-27.
35. Zhang, A., Sun, H., Wu, G., Sun, W., Ye, Y., & Wang, X. (2013). Proteomics analysis of hepatoprotective effects for scoparone using MALDI-TOF/TOF mass spectrometry with bioinformatics. OMICS. doi: 10.1089/omi.2012.0064.
36. Lopez, M. F., Mikulskis, A., Kuzdzal, S., Golenko, E., Petricoin, E. F., 3rd, Liotta, L. A., Patton, W. F., Whiteley, G. R., Rosenblatt, K., Gurnani, P., Nandi, A., Neill, S., Cullen, S., O'Gorman, M., Sarracino, D., Lynch, C., Johnson, A., Mckenzie, W., & Fishman, D. (2007). A novel, high-throughput workflow for discovery, and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples. Clinical Chemistry, 53(6), 1067-74.
37. Longo, C., Patanarut, A., George, T., Bishop, B., Zhou, W., Fredolini, C., Ross, M. M., Espina, V., Pellacani, G., Petricoin, E. F., 3rd, Liotta, L. A., & Luchini, A. (2009). Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkers. PLoS One, 4(3), e4763.
38. Bijian, K., Mlynarek, A. M., Balys, R. L., Jie, S., Xu, Y., Hier, M. P., Black, M. J., Di Falco, M. R., LaBoissiere, S., & Alaoui-Jamali, M. A. (2009). Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment. Journal of Proteome Research, 8(5), 2173-85.
39. Chen, C. S., Sullivan, S., Anderson, T., Tan, A. C., Alex, P. J., Brant, S. R., Cuffari, C., Bayless, T. M., Talor, M. V., Burek, C. L., Wang, H., Li, R., Datta, L. W., Wu, Y., Winslow, R. L., Zhu, H., & Li, X. (2009). Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip. Molecular & Cellular Proteomics, 8(8), 1765-76.
40. Alterman, M. A., Gogichayeva, N. V., & Kornilayev, B. A. (2004). Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based amino acid analysis. Analytical Biochemistry, 335(2), 184-91.
41. Mehan, M. R., Ayers, D., Thirstrup, D., Xiong, W., Ostroff, R. M., Brody, E. N., Walker, J. J., Gold, L., Jarvis, T. C., Janjic, N., Baird, G. S., & Wilcox, S. K. (2012). Protein signature of lung cancer tissues. PLoS One, 7(4), e35157.
42. Brown, D. L., Andreotti, R. F., Lee, S. I., Dejesus Allison, S. O., Bennett, G. L., Dubinsky, T., Glanc, P., Horrow, M. M., Lev-Toaff, A. S., Horowitz, N. S., Podrasky, A. E., Scoutt, L. M., & Zelop, C. M. (2010). ACR appropriateness criteria© ovarian cancer screening. Ultrasound Quarterly, 26(4), 219-23.
43. Boyce, E. A., & Kohn, E. C. (2005). Ovarian cancer in the proteomics era: diagnosis, prognosis, and therapeutic targets. International Journal of Gynecological Cancer, 15(Suppl 3), 266-73.
44. Lorkova, L., Pospisilova, J., Lacheta, J., Leahomschi, S., Zivny, J., Cibula, D., Zivny, J., & Petrak, J. (2012). Decreased concentrations of retinol-binding protein 4 in sera of epithelial ovarian cancer patients: a potential biomarker identified by proteomics. Oncology Reports, 27(2), 318-24.
45. Clarke, C. H., Yip, C., Badgwell, D., Fung, E. T., Coombes, K. R., Zhang, Z., Lu, K. H., & Bast, R. C., Jr. (2011). Proteomic biomarkers apolipoprotein A1, truncated transthyretin, and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer. Gynecologic Oncology, 122(3), 548-53.
46. Sun, C., Rosendahl, A. H., Ansari, D., & Andersson, R. (2011). Proteome-based biomarkers in pancreatic cancer. World Journal of Gastroenterology, 17(44), 4845-52.
47. Matsubara, J., Honda, K., Ono, M., Tanaka, Y., Kobayashi, M., Jung, G., Yanagisawa, K., Sakuma, T., Nakamori, S., Sata, N., Nagai, H., Ioka, T., Okusaka, T., Kosuge, T., Tsuchida, A., Shimahara, M., Yasunami, Y., Chiba, T., Hirohashi, S., & Yamada, T. (2011). Reduced plasma level of CXC chemokine ligand 7 in patients with pancreatic cancer. Cancer Epidemiology, Biomarkers & Prevention, 20(1), 160-71.
48. Guo, J., Wang, W., Liao, P., Lou, W., Ji, Y., Zhang, C., Wu, J., & Zhang, S. (2009). Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis. Cancer Science, 100(12), 2292-301.
49. Böhm, D., Keller, K., Wehrwein, N., Lebrecht, A., Schmidt, M., Kölbl, H., & Grus, F. H. (2011). Serum proteome profiling of primary breast cancer indicates a specific biomarker profile. Oncology Reports, 26(5), 1051-6.
50. Zeng, Z., Hincapie, M., Pitteri, S. J., Hanash, S., Schalkwijk, J., Hogan, J. M., Wang, H., & Hancock, W. S. (2011). A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome. Analytical Chemistry, 83(12), 4845-54.
51. Pietrowska, M., Polanska, J., Marczak, L., Behrendt, K., Nowicka, E., Stobiecki, M., Polanski, A., Tarnawski, R., & Widlak, P. (2010). Mass spectrometry-based analysis of therapy-related changes in serum proteome patterns of patients with early-stage breast cancer. Journal of Translational Medicine, 8, 66.
52. Pietrowska, M., Marczak, L., Polanska, J., Behrendt, K., Nowicka, E., Walaszczyk, A., Chmura, A., Deja, R., Stobiecki, M., Polanski, A., Tarnawski, R., & Widlak, P. (2009). Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer. Journal of Translational Medicine, 7, 60.
53. Li, Y., Zeng, J., Shi, J., Wang, M., Rao, M., Xue, C., Du, Y., & He, Z. G. (2010). A proteome-scale identification of novel antigenic proteins in Mycobacterium tuberculosis toward diagnostic and vaccine development. Journal of Proteome Research, 9(9), 4812-22.
54. Brust, B., Lecoufle, M., Tuaillon, E., Dedieu, L., Canaan, S., Valverde, V., & Kremer, L. (2011). Mycobacterium tuberculosis lipolytic enzymes as potential biomarkers for the diagnosis of active tuberculosis. PLoS One, 6(9), e25078.
55. Liu, J. Y., Jin, L., Zhao, M. Y., Zhang, X., Liu, C. B., Zhang, Y. X., Li, F. J., Zhou, J. M., Wang, H. J., & Li, J. C. (2011). New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Clinical Chemistry and Laboratory Medicine, 49(10), 1727-33.
56. Yang, S. Y., Adelstein, J., & Kassis, A. I. (2010). Putative molecular signatures for the imaging of prostate cancer. Expert Review of Molecular Diagnostics, 10(1), 65-74.
57. Yocum, A. K., Khan, A. P., Zhao, R., & Chinnaiyan, A. M. (2010). Development of selected reaction monitoring-MS methodology to measure peptide biomarkers in prostate cancer. Proteomics, 10(19), 3506-14.
58. Larkin, S. E., Zeidan, B., Taylor, M. G., Bickers, B., Al-Ruwaili, J., Aukim-Hastie, C., & Townsend, P. A. (2010). Proteomics in prostate cancer biomarker discovery. Expert Review of Proteomics, 7(1), 93-102.
59. Steuber, T., O'Brien, M. F., & Lilja, H. (2008). Serum markers for prostate cancer: a rational approach to the literature. European Urology, 54(1), 31-40.
60. Byrne, J. C., Downes, M. R., O'Donoghue, N., O'Keane, C., O'Neill, A., Fan, Y., Fitzpatrick, J. M., Dunn, M., & Watson, R. W. (2009). 2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer. Journal of Proteome Research, 8(2), 942-57.
61. Sardana, G., Jung, K., Stephan, C., & Diamandis, E. P. (2008). Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers. Journal of Proteome Research, 7(8), 3329-38.
62. Zhang, X., Yin, X., Yu, H., Liu, X., Yang, F., Yao, J., Jin, H., & Yang, P. (2012). Quantitative proteomic analysis of serum proteins in patients with Parkinson's disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry. Analyst, 137(2), 490-5.
63. Li, Y. H., Wang, J., Zheng, X. L., Zhang, Y. L., Li, X., Yu, S., He, X., & Chan, P. (2011). Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry combined with magnetic beads for detecting serum protein biomarkers in Parkinson's disease. European Neurology, 65(2), 105-11.
64. Gressner, O. A., Weiskirchen, R., & Gressner, A. M. (2007). Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clinica Chimica Acta, 381(2), 107-13.
65. Mölleken, C., Sitek, B., Henkel, C., Poschmann, G., Sipos, B., Wiese, S., Warscheid, B., Broelsch, C., Reiser, M., Friedman, S. L., Tornøe, I., Schlosser, A., Klöppel, G., Schmiegel, W., Meyer, H. E., Holmskov, U., & Stühler, K. (2009). Detection of novel biomarkers of liver cirrhosis by proteomic analysis. Hepatology, 49(4), 1257-66.
66. Uto, H., Kanmura, S., Takami, Y., & Tsubouchi, H. (2010). Clinical proteomics for liver disease: a promising approach for discovery of novel biomarkers. Proteome Sci., 8, 70.
67. Ward, D. G., Suggett, N., Cheng, Y., Wei, W., Johnson, H., Billingham, L. J., Ismail, T., Wakelam, M. J., Johnson, P. J., & Martin, A. (2006). Identification of serum biomarkers for colon cancer by proteomic analysis. British Journal of Cancer, 94(12), 1898-905.
68. Ma, Y. L., Peng, J. Y., Zhang, P., Huang, L., Liu, W. J., Shen, T. Y., Chen, H. Q., Zhou, Y. K., Zhang, M., Chu, Z. X., & Qin, H. L. (2009). Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology. Journal of Proteome Research, 8(10), 4525-35.
69. Kelly, P., Paulin, F., Lamont, D., Baker, L., Clearly, S., Exon, D., & Thompson, A. (2012). Pretreatment plasma proteomic markers associated with survival in esophageal cancer. British Journal of Cancer, 106(5), 955-61.
70. Liu, C., Pan, C., Wang, H., & Yong, L. (2011). Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifying biomarkers of laryngeal carcinoma. Tumor Biology, 32(6), 1139-45.
71. Tan, Y., Ma, S. Y., Wang, F. Q., Meng, H. P., Mei, C., Liu, A., & Wu, H. R. (2011). Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer. Oncology Reports, 26(4), 853-9.
72. Wang, Y. S., Cao, R., Jin, H., Huang, Y. P., Zhang, X. Y., Cong, Q., He, Y. F., & Xu, C. J. (2011). Altered protein expression in serum from endometrial hyperplasia and carcinoma patients. Journal of Hematology & Oncology, 4, 15.
73. Ostroff, R. M., Bigbee, W. L., Franklin, W., Gold, L., Mehan, M., Miller, Y. E., Pass, H. I., Rom, W. N., Siegfried, J. M., Stewart, A., Walker, J. J., Weissfeld, J. L., Williams, S., Zichi, D., & Brody, E. N. (2010). Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer. PLoS One, 5(12), e15003.
74. Han, M. H., Hwang, S. I., Roy, D. B., Lundgren, D. H., Price, J. V., Ousman, S. S., Fernald, G. H., Gerlitz, B., Robinson, W. H., Baranzini, S. E., Grinnell, B. W., Raine, C. S., Sobel, R. A., Han, D. K., & Steinman, L. (2008). Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature, 451(7182), 1076-81.